CADASIL: A Monogenic NOTCH3 Disorder with Complex Genetic, Epigenetic, and Environmental Modifiers—Implications for Precision Medicine

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy (CADASIL) is the prototypical monogenic cerebral small vessel disease caused by pathogenic variants in NOTCH3. Despite its well-established genetic basis, CADASIL ex-hibits substantial clinical, radiological, and biological heterogeneity, indicating that dis-ease expression is shaped by interactions between the causal variant and additional ge-netic, epigenetic, sex-related, and environmental modifiers. This review provides an inte-grative overview of CADASIL pathogenesis, from NOTCH3 structure and signaling ab-normalities to vascular dysfunction and cerebral injury. We examine genotype–phenotype relationships, including the effects of variant location and non-canonical variants, and discuss the potential contribution of modifier loci, vascular risk factors, and sex-specific mechanisms. Emerging evidence implicates vascular smooth muscle cell dysfunction, endoplasmic reticulum and oxidative stress, inflammation, complement activation, ex-tracellular-matrix remodeling, and alterations of the neurovascular unit in disease pro-gression. We further evaluate genetic, structural, physiological, and molecular biomarkers, highlighting the potential of multimodal approaches to characterize disease burden, iden-tify early vascular dysfunction, and improve patient stratification. Finally, we discuss current supportive and preventive management alongside emerging therapeutic strategies targeting NOTCH3 production and processing, extracellular protein accumulation, vas-cular-cell dysfunction, and downstream pathological pathways. Although precision medicine in CADASIL remains primarily focused on integrated diagnosis and phenotyp-ing, advances in patient-specific models, biomarker development, and mecha-nism-informed interventions provide a framework for future therapeutic development. A better understanding of disease modifiers and pathogenic pathways will be essential to improve prognostic assessment and advance individualized management.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-13
DOI
https://doi.org/10.20944/preprints202611.1451.v1
Primary Topic
Cerebrovascular and genetic disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

CADASIL: A Monogenic NOTCH3 Disorder with Complex Genetic, Epigenetic, and Environmental Modifiers—Implications for Precision Medicine

Carmela Rita Balistreri, Filippo Brighina, Giuseppe La Tona, Aurora Meli
1 links
Preprints.org
Cerebrovascular and genetic disorders
preprint

CADASIL: A Monogenic NOTCH3 Disorder with Complex Genetic, Epigenetic, and Environmental Modifiers—Implications for Precision Medicine

Carmela Rita Balistreri, Filippo Brighina, Giuseppe La Tona, Aurora Meli
preprint en

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy (CADASIL) is the prototypical monogenic cerebral small vessel disease caused by pathogenic variants in NOTCH3. Despite its well-established genetic basis, CADASIL ex-hibits substantial clinical, radiological, and biological heterogeneity, indicating that dis-ease expression is shaped by interactions between the causal variant and additional ge-netic, epigenetic, sex-related, and environmental modifiers. This review provides an inte-grative overview of CADASIL pathogenesis, from NOTCH3 structure and signaling ab-normalities to vascular dysfunction and cerebral injury. We examine genotype–phenotype relationships, including the effects of variant location and non-canonical variants, and discuss the potential contribution of modifier loci, vascular risk factors, and sex-specific mechanisms. Emerging evidence implicates vascular smooth muscle cell dysfunction, endoplasmic reticulum and oxidative stress, inflammation, complement activation, ex-tracellular-matrix remodeling, and alterations of the neurovascular unit in disease pro-gression. We further evaluate genetic, structural, physiological, and molecular biomarkers, highlighting the potential of multimodal approaches to characterize disease burden, iden-tify early vascular dysfunction, and improve patient stratification. Finally, we discuss current supportive and preventive management alongside emerging therapeutic strategies targeting NOTCH3 production and processing, extracellular protein accumulation, vas-cular-cell dysfunction, and downstream pathological pathways. Although precision medicine in CADASIL remains primarily focused on integrated diagnosis and phenotyp-ing, advances in patient-specific models, biomarker development, and mecha-nism-informed interventions provide a framework for future therapeutic development. A better understanding of disease modifiers and pathogenic pathways will be essential to improve prognostic assessment and advance individualized management.

Preprints.org
Good health and well-being
Cerebrovascular and genetic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon